Table 3.
Robotic group n = 30 | Open/lap group n = 60 | p values | ||||||
---|---|---|---|---|---|---|---|---|
T stage | Rectal | Colon | Total | Rectal | Colon | Total | 0.24 | |
T0 | 1 | 0 | 1 | 0 | 0 | 0 | ||
T1 | 5 | 0 | 5 | 1 | 1 | 2 | ||
T2 | 5 | 3 | 8 | 9 | 4 | 15 | ||
T3 | 11 | 4 | 15 | 12 | 24 | 36 | ||
T4 | 1 | 0 | 1 | 1 | 8 | 9 | ||
N stage | ||||||||
N0 | 17 | 5 | 22 | 14 | 17 | 31 | ||
N1 | 5 | 1 | 6 | 8 | 12 | 20 | ||
N2 | 1 | 1 | 2 | 1 | 8 | 9 | ||
M stage | ||||||||
M0 | 23 | 7 | 30 | 22 | 32 | 54 | ||
M1 | 0 | 0 | 0 | 1 | 5 | 6 | ||
Resection margin status | 0.9 | |||||||
R0 | 23 | 7 | 30 | 23 | 35 | 58 | ||
R1 | 0 | 0 | 0 | 0 | 2 | 2 | ||
CRM | 0.08 | |||||||
Mesorectal fascia | 22/23 | 18/23 | ||||||
Intra-mesorectal | 1/23 | 5/23 | ||||||
Median number of lymph nodes | 16 | 17 | 0.9 | |||||
(Range) | (3–53) | (5–38) | ||||||
(IQR) | (14–22) | (13–23) | ||||||
Adjuvant therapy |
4/30 (13.3%) 4 Chemotherapy |
28/60 (46.6%) 27 Chemotherapy 1 Liver lesion ablation |
0.0001 |